Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs
- PMID: 1789513
Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs
Abstract
To determine the drug dose required to inhibit platelet reactivity by at least 50%, 2 drug regimens were evaluated in heartworm-negative, heartworm-infected, and heartworm-infected dogs embolized with dead heartworms. Aspirin, or a combination of aspirin and dipyridamole, were administered to 2 groups of Beagles (n = 5 each) for 5 to 9 days; a third group of 5 Beagles served as nontreated controls. For heartworm-negative dogs, mean (+/- SD) aspirin dosage that inhibited collagen-induced platelet reactivity by at least 50% was 6 (+/- 2) mg/kg of body weight given once daily. The aspirin/diphridamole combination dosage was 1 mg of each drug/kg given every 12 hours. All dogs (n = 15) were implanted with 7 adult heartworms each and remedicated (or not treated) beginning at 21 days after heartworm implantation. In heartworm-infected dogs, mean aspirin dosage required to inhibit collagen-induced platelet reactivity greater than or equal to 50% was 10 (+/- 6) mg/kg. Mean dosage of aspirin/dipyridamole combination was 1.6 +/- (0.5) mg of each drug/kg given every 12 hours. When platelet reactivity in response to collagen was determined to be inhibited by at least 50% in all medicated dogs, each dog (n = 15) was embolized with 7 dead adult heartworms to mimic heartworm adulticidal treatment. Platelet reactivity was monitored for 21 days after treatment, and drug dose was adjusted to maintain platelet inhibition by at least 50%. In embolized dogs, mean aspirin dosage was 17 (+/- 14) mg/kg given once daily. Mean dosage of the aspirin/dipyridamole combination was 2.8 (+/- 1.3) mg of each drug/kg given every 12 hours. All dogs (n = 15) were euthanatized 21 days after heartworm embolization. Each lung lobe was evaluated for severity of lesions and presence of organized or fibrinous thrombi. Lesion severity in the aspirin- and aspirin/dipyridamole-treated dogs was not significantly different from that in control dogs.
Similar articles
-
Effects of treatment with ticlopidine in heartworm-negative, heartworm-infected, and embolized heartworm-infected dogs.Am J Vet Res. 1991 Dec;52(12):2000-6. Am J Vet Res. 1991. PMID: 1789514
-
Platelet function, antithrombin-III activity, and fibrinogen concentration in heartworm-infected and heartworm-negative dogs treated with thiacetarsamide.Am J Vet Res. 1991 Dec;52(12):1986-91. Am J Vet Res. 1991. PMID: 1789512
-
Enhanced platelet reactivity in heartworm-infected dogs.Am J Vet Res. 1989 Sep;50(9):1544-7. Am J Vet Res. 1989. PMID: 2802330
-
The safety-net story about macrocyclic lactone heartworm preventives: a review, an update, and recommendations.Vet Parasitol. 2005 Oct 24;133(2-3):197-206. doi: 10.1016/j.vetpar.2005.04.005. Epub 2005 Apr 26. Vet Parasitol. 2005. PMID: 16198822 Review.
-
Aspirin and other platelet-aggregation inhibiting drugs.Med J Aust. 1985 Jan 7;142(1):41-7. Med J Aust. 1985. PMID: 3880861 Review.
Cited by
-
2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.J Vet Emerg Crit Care (San Antonio). 2022 May;32(3):289-314. doi: 10.1111/vec.13204. Epub 2022 May 2. J Vet Emerg Crit Care (San Antonio). 2022. PMID: 35499966 Free PMC article.
-
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin.J Vet Intern Med. 2013 Jan-Feb;27(1):141-9. doi: 10.1111/jvim.12022. Epub 2012 Dec 26. J Vet Intern Med. 2013. PMID: 23278865 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources